Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 47, 2018 - Issue 3
171
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Association between CD226 polymorphism and soluble levels in rheumatoid arthritis: Relationship with clinical activity

ORCID Icon, , , , , & show all
Pages 264-278 | Received 10 Aug 2017, Accepted 31 Dec 2017, Published online: 10 Jan 2018

References

  • Aletaha D , Neogi T , Silman AJ , et al. (2010). 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis, 69, 1580–1588. doi:10.1136/ard.2010.138461.
  • Dardalhon V , Schubart AS , Reddy J , et al. (2005). CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol, 175, 1558–1565. doi:10.4049/jimmunol.175.3.1558.
  • Deshmukh HA , Maiti AK , Kim-Howard XR , et al. (2011). Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction. J Rheumatol, 38, 1866–1870. doi:10.3899/jrheum.110199.
  • Dieudéa P , Cornélisa F. (2005). Genetic basis of rheumatoid arthritis. Joint Bone Spine, 72, 520–526. doi:10.1016/j.jbspin.2005.09.001.
  • Dougall WC , Kurtulus S , Smyth MJ , Anderson AC. (2017, Mar). TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. Immunol Rev, 276, 112–120. doi:10.1111/imr.2017.276.issue-1.
  • Douroudis K , Kingo K , Silm H , et al. (2010, May). The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. J Dermatol Sci, 58, 160–161. doi:10.1016/j.jdermsci.2010.03.015.
  • Douroudis K , Nemvalts V , Rajasalu T , et al. (2009, Nov). The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens, 74, 417–419. doi:10.1111/tan.2009.74.issue-5.
  • Du Y , Shen L-X , Yu L-K , et al. (2012). The CD226 gene in susceptibility of rheumatoid arthritis in the Chinese Han population. Rheumatol Int, 32, 1299–1304. doi:10.1007/s00296-011-1796-z.
  • Duda PW , Schmied MC , Cook SL , et al. (2000). Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest, 105, 967–976. doi:10.1172/JCI8970.
  • Elishmereni M , Bachelet I , Levi-Schaffer F . (2008, May). DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders. Curr Opin Investig Drugs, 9, 491–496.
  • Hafler JP , Maier LM , Cooper JD , et al. (2009, Jan). CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun, 10, 5–10. doi:10.1038/gene.2008.82.
  • Hashemi M , Zakeri Z , Eskandari-Nasab E , et al. (2013, Oct). CD226 rs763361 (Gly307Ser) Polymorphism Is Associated with Susceptibility to Rheumatoid Arthritis in Zahedan, Southeast Iran. Iran Biomed J, 17, 194–199.
  • Kanaya M , Shibuya K , Hirochika R , et al. (2016, Jun 3). Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease. PLoS One, 11, e0154173. doi:10.1371/journal.pone.0154173.
  • Liu R , Xu N , Wang X , et al. (2012). Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis. Mol Biol Rep, 39, 6915–6922. doi:10.1007/s11033-012-1518-y.
  • Lofgren SE , Delgado-Vega AM , Gallant CJ , et al. (2010, Nov). A 3ʹ-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum, 62, 3404–3414. doi:10.1002/art.27677.
  • Lozano E , Joller N , Cao Y , et al. (2013, Oct 1). The CD226/CD155 interaction regulates the pro-inflammatory (Th1/Th17)/anti-inflammatory (Th2) balance in humans. J Immunol, 191, 10. doi:10.4049/jimmunol.1300945.
  • Lucotte G , Mercier G . (2003). Brief communication: Y-chromosome haplotypes in Egypt. Am J Phys Anthropol, 121, 63–66. doi:10.1002/ajpa.10190.
  • Maiti AK , Kim-Howard X , Viswanathan P , et al. (2010). Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatol Oxf Engl, 49, 1239–1244. doi:10.1093/rheumatology/kep470.
  • Manni F , Leonardi P , Barakat A , et al. (2002 Oct). Y-chromosome analysis in Egypt suggests a genetic regional continuity in Northeastern Africa. Hum Biol, 74, 645–658. doi: 10.1353/hub.2002.0054.
  • Mohamed RA , Abd Elazeem MI . (2017, May). Genetic influence of DNAM-1 (DNAX accessory molecule-1) gene polymorphism (rs 763361) on susceptibility and disease activity of systemic lupus erythematosus and rheumatoid arthritis in Egyptian patients. Comp Clin Path, 26, 543–552. doi:10.1007/s00580-017-2406-6.
  • Mosaad YM , El-Bassiony SR , El-Ghaweet AE , et al. (2015, Aug). TIM-1 rs41297579 G>A (−1454) and TIM-4 rs7700944 gene polymorphisms as possible risk factor for rheumatoid arthritis: relation to activity and severity. Int J Immunogenet, 42, 254–264. doi:10.1111/iji.12201.
  • Mosaad YM , Hammad EM , Fawzy Z , et al. (2014, May). Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum Immunol, 75, 452–461. doi:10.1016/j.humimm.2014.02.009.
  • Nabekura T , Shibuya K , Takenaka E , et al. (2010). Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice. Proc Natl Acad Sci USA, 107, 18593–18598. doi:10.1073/pnas.1005582107.
  • Nielsen N , Pascal V , Fasth AE , et al. (2014). Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Immunology, 142, 581–593. doi:10.1111/imm.12271.
  • Peakall R , Smouse PE . (2012). GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics, 28, 2537–2539. doi:10.1093/bioinformatics/bts460.
  • Prasad P , Kumar A , Gupta R , et al. (2012). Caucasian and Asian specific rheumatoid arthritis risk loci reveal limited replication and apparent allelic heterogeneity in north Indians. PLoS One, 7, e31584. doi:10.1371/journal.pone.0031584.
  • Prevoo ML , Van ‘T Hof MA , Kuper HH , et al. (1995, Jan). Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum, 38, 44–48. doi:10.1002/art.1780380107.
  • Qiu Z-X, Zhang K, Qiu X-S, et al. (2013). CD226 Gly307Ser association with multiple autoimmune diseases: a meta-analysis. Hum Immunol, 74, 249–255. doi:10.1016/j.humimm.2012.10.009.
  • Shibuya A , Campbell D , Hannum C , et al. (1996, Jun). DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity, 4, 573–581. doi:10.1016/S1074-7613(00)70060-4.
  • Shibuya K , Lanier LL , Phillips JH , et al. (1999, Nov). Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity, 11, 615–623. doi:10.1016/S1074-7613(00)80136-3.
  • Shibuya K , Shirakawa J , Kameyama T , et al. (2003, Dec). CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med, 198, 1829–1839. doi:10.1084/jem.20030958.
  • Shirakawa J , Shibuya K , Shibuya A . (2005). Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). Int Immunol, 17, 217–223. doi:10.1093/intimm/dxh199.
  • Song G , Bae SC , Choi S , et al. (2012, Dec). Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Lupus, 21, 1522–1530. doi:10.1177/0961203312458840.
  • Suzuki T , Ikari K , Kawaguchi Y , et al. (2013, Jan). Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility in Japanese rheumatoid arthritis patients. Mod Rheumatol, 23, 200–202. doi:10.3109/s10165-012-0609-x.
  • Takahashi N , Sugaya M , Suga H , et al. (2017, Apr 7). Increased soluble CD226 in sera of patients with cutaneous T-Cell lymphoma mediating cytotoxic activity against tumor cells via CD155. J Invest Dermatol, 137, 1766–1773. doi:10.1016/j.jid.2017.03.025.
  • Ueda H , Howson JM , Esposito L , et al. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506–511. doi:10.1038/nature01621.
  • Wieczorek S , Hoffjan S , Chan A , et al. (2009, Sep). Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener’s granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun, 10, 591–595. doi:10.1038/gene.2009.44.
  • Xiong P , Sang HW , Zhu M . (2015, Nov). Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity. Immunology, 146, 369–378. doi:10.1111/imm.12516.
  • Xu Z , Jin B . (2010, Jan). A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell Mol Immunol, 7, 11–19. doi:10.1038/cmi.2009.108.
  • Yarwood A , Huizinga TW , Worthington J . (2016, Feb). The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. Rheumatology (Oxford), 55, 199–209. doi:10.1093/rheumatology/keu323.
  • Yu X , Harden K , Gonzalez LC , et al. (2009). The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol, 10, 48–57. doi:10.1038/ni.1674.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.